Testicular Tuberculosis after Intravesical BCG for Urinary Bladder Cancer: A Role of FDG PET-CT
Bacillus Calmette-Guërin (BCG) has been traditionally used as a vaccine against tuberculosis (TB), which contains live, attenuated strain of <i>Mycobacterium bovis</i>. However, intravesical BCG administration has been used as an immunological treatment of superficial bladder cancer. Complications after bladder instillation of BCG are rare. We report a case of carcinoma urinary bladder with histopathologically proven granulomatous epididymo-orchitis (TB) after treatment with intravesical BCG.
Authors
- Thara Pratap (ORCID: https://orcid.org/0000-0002-6667-9453)
- R Arun Visakh
- Senthil Raja
- V. Gangadharan (ORCID: https://orcid.org/0000-0001-8979-3091)
- Renu Mariam Thomas
Institutions
- Lakeshore Hospital (IN)
Publication Details
- Journal
- Indian Journal of Nuclear Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.4103/ijnm.ijnm_115_24
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00